Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Articles published by T-knife Therapeutics
T-knife Therapeutics Appoints Christoph Broja to its Board of Directors
July 01, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Presents Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting Demonstrating a Potential Best-in-Class PRAME Targeted TCR-T Therapy
April 25, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Announces Five Presentations at American Association for Cancer Research (AACR) Annual Meeting
March 25, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Welcomes Dr. Sophie Papa to its Board of Directors
February 20, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics to Participate in Two Investor Conferences in March
February 12, 2025
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Announces the Appointment of Simone Silva Steiner, Ph.D., as Chief Technical Operations Officer
November 06, 2023
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Announces Four Presentations at the Upcoming Society for Immunotherapy of Cancer (SITC) Annual Meeting
September 27, 2023
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Presents Preclinical Data on the Anti-Tumor Activity of TK-8001 at ISCT Annual Meeting
June 01, 2023
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Announces the Appointment of Behzad Kharabi, M.D., as Chief Medical Officer
February 08, 2023
From
T-knife Therapeutics
Via
GlobeNewswire
T-knife Therapeutics Announces Dosing of First Patient with TK-8001 in the IMAG1NE Phase 1/2 Clinical Trial
October 20, 2022
From
T-knife Therapeutics
Via
GlobeNewswire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.